-
1 Comment
Marksans Pharma Limited is currently in a long term uptrend where the price is trading 41.4% above its 200 day moving average.
From a valuation standpoint, the stock is 66.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.6.
Marksans Pharma Limited's total revenue rose by 24.6% to $4B since the same quarter in the previous year.
Its net income has increased by 102.0% to $589M since the same quarter in the previous year.
Finally, its free cash flow grew by 76.2% to $876M since the same quarter in the previous year.
Based on the above factors, Marksans Pharma Limited gets an overall score of 5/5.
| Sector | Healthcare |
|---|---|
| Industry | Drug Manufacturers - General |
| Exchange | NSE |
| CurrencyCode | INR |
| ISIN | INE750C01026 |
| Market Cap | 108B |
|---|---|
| PE Ratio | 27.38 |
| Target Price | 299.3333 |
| Dividend Yield | 0.3% |
| Beta | 1.5 |
Marksans Pharma Limited, together with its subsidiaries, engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally. The company offers products in the pain management, upper respiratory, cardiovascular, central nervous system, anti-diabetic, gastrointestinal, analgesics, upper respiratory, ear care, skincare, anticancer, anti-ulcerative, anti-allergy, antiviral, dietary, cardiac, dermatology, antihistamines, anti-fungal, anti-viral, laxatives, and cold and cough therapeutic areas. It also produces a range of solid oral dosage forms, including tablets and hard gelatin capsules; soft gels; essential oils; ointments; and creams and liquids, as well as prescription drugs. The company provides its products to supermarkets, high street retailers, pharmacy chains, and wholesalers. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for MARKSANS.NSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
